Antiparkinson-like effects of a novel neurotensin analog in unilaterally 6-hydroxydopamine lesioned rats
Authors:
- Mona BoulesMBMona Boules
- Lewis WarringtonLWLewis Warrington
- Abdul FauqAFAbdul Fauq
- Daniel McCormickDMDaniel McCormick
- Elliott RichelsonERElliott Richelson
- 1 October 2001
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 428 (2) , 227-233
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- A novel neurotensin peptide analog given extracranially decreases food intake and weight in rodentsBrain Research, 2000
- Effects of a novel neurotensin peptide analog given extracranially on CNS behaviors mediated by apomorphine and haloperidolBrain Research, 2000
- Characterization of neurotensin-like immunoreactivity in human basal ganglia: Increased neurotensin levels in substantia nigra in Parkinson's diseasePeptides, 1995
- Neurotensin, substance P, delta and mu opioid receptors are decreased in basal ganglia of parkinson's disease patientsNeuroscience, 1994
- Bilateral modulation of [3H]neurotensin binding by unilateral intrastriatal 6-hydroxydopamine injections: evidence from a receptor autoradiographic studyBrain Research, 1991
- Intraventricular injection of neurotensin reduces dopamine D2 agonist binding in rat forebrain and intermediate lobe of the pituitary gland. Relationship to serum hormone levels and nerve terminal coexistenceBrain Research, 1990
- Effects of neurotensin on regional brain concentrations of dopamine, serotonin and their main metabolitesNeuropeptides, 1990
- Neurotensin receptors in parkinson's disease and progressive supranuclear palsy: an autoradiographic study in basal gangliaNeuroscience, 1990
- Alterations in regional brain concentrations of neurotensin and bombesin in Parkinson's diseaseAnnals of Neurology, 1985
- Neurotensin blocks certain amphetamine-induced behavioursNature, 1981